Today: 7 February 2026
Subscribe
Browse Category

NYSE:CMI News 11 December 2025 - 7 February 2026

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
7 February 2026
··
Caterpillar stock price jumps 7% as Dow tops 50,000 — what’s next for CAT shares

Caterpillar stock price jumps 7% as Dow tops 50,000 — what’s next for CAT shares

Caterpillar shares jumped 7.1% to $726.20 on Friday, pushing the Dow above 50,000 for the first time. Group President Bob De Lange exercised 20,000 options and sold 16,070 shares at about $705, SEC filings showed. The company warned tariffs could cut 2026 margins by $2.6 billion. U.S. consumer sentiment rose, but job and price worries persisted.
7 February 2026
····
Cummins stock price sinks after Accelera charge; traders eye 2026 outlook and data-center demand

Cummins stock price sinks after Accelera charge; traders eye 2026 outlook and data-center demand

Cummins shares dropped 10.7% to $540.38 after fourth-quarter results and $218 million in charges tied to its Accelera hydrogen unit. Revenue rose 1% to $8.5 billion, but investors focused on margin pressure from tariffs and a strategic review of Accelera. CEO Jennifer Rumsey said North American truck demand may improve late 2026, while data-center backup power orders remain strong.
6 February 2026
·
Cummins stock in focus as it pulls back on electrolyzers and maps 2026 outlook

Cummins stock in focus as it pulls back on electrolyzers and maps 2026 outlook

Cummins will halt new commercial ventures in its electrolyzer division and took a $218 million charge for the segment in Q4. Shares rose about 0.5% in premarket trading after the company projected 2026 revenue growth of 3% to 8%, citing steady demand for data-center backup power. Fourth-quarter revenue rose 1% to $8.5 billion, while net income reached $593 million.
5 February 2026
··
Caterpillar stock drifts into year-end as Fed minutes loom and trading stays thin

Caterpillar stock drifts into year-end as Fed minutes loom and trading stays thin

NEW YORK, December 28, 2025, 22:48 ET — Market closed Caterpillar Inc shares ended Friday slightly lower, closing down 0.13% at $583.00 as trading stayed subdued ahead of the final sessions of 2025. FinancialContent The heavy-equipment maker is widely watched as a read on cyclical demand, and the muted move comes as investors head into year-end looking for fresh direction from rates and broader market leadership. Reuters+1 Minutes from the Federal Reserve’s December meeting are due Tuesday, and markets are focused on what they signal about the pace of rate cuts in 2026 after the central bank lowered its benchmark
29 December 2025
·····
Cummins (CMI) Stock Near Record Highs as AI Data Center Demand Collides With Hydrogen Setback – Latest News, Forecasts and Analysis

Cummins (CMI) Stock Near Record Highs as AI Data Center Demand Collides With Hydrogen Setback – Latest News, Forecasts and Analysis

As of December 11, 2025 Key Points Cummins stock today: price, performance and valuation Cummins shares are trading around $524–$525 in Thursday’s session, giving the company a market value in the low‑to‑mid $70 billion range.MarketBeat On December 10, the stock closed at $524.53, up 4.9% on the day and setting a new 52‑week high, with intraday trade reaching roughly $526.50.MarketWatch+2StockAnalysis+2 That move extended a remarkable rally: according to InvestingPro data, Cummins is up about 39% over the past 12 months and 54% over the last six months.Investing.com Australia Performance has far outpaced both the S&P 500 and the industrials sector.
11 December 2025
··

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Go toTop